Abbott has secured the CE mark in Europe for its Esprit BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a device intended to treat peripheral artery disease (PAD) below the knee ...

Becton, Dickinson and Company (BD) is set to initiate a multi-centre registry study, XTRACT, of the Rotarex Atherectomy System, aimed at measuring real-world outcomes for individuals with ...